186 related articles for article (PubMed ID: 32706492)
21. Phase-Separable Polyisobutylene Palladium-PEPPSI Precatalysts: Synthesis and Application in Buchwald-Hartwig Amination.
Balogh J; Hlil AR; El-Zoghbi I; Rafique MG; Chouikhi D; Al-Hashimi M; Bazzi HS
Macromol Rapid Commun; 2017 Aug; 38(15):. PubMed ID: 28627077
[TBL] [Abstract][Full Text] [Related]
22. Phenylboronic Ester-Activated Aryl Iodide-Selective Buchwald-Hartwig-Type Amination toward Bioactivity Assay.
Dhital RN; Sen A; Hu H; Ishii R; Sato T; Yashiroda Y; Kimura H; Boone C; Yoshida M; Futamura Y; Hirano H; Osada H; Hashizume D; Uozumi Y; Yamada YMA
ACS Omega; 2022 Jul; 7(28):24184-24189. PubMed ID: 35874269
[TBL] [Abstract][Full Text] [Related]
23. Flexible Steric Bulky Bis(Imino)acenaphthene (BIAN)-Supported N-Heterocyclic Carbene Palladium Precatalysts: Catalytic Application in Buchwald-Hartwig Amination in Air.
Lan XB; Li Y; Li YF; Shen DS; Ke Z; Liu FS
J Org Chem; 2017 Mar; 82(6):2914-2925. PubMed ID: 28244313
[TBL] [Abstract][Full Text] [Related]
24. The application of ubiquitin ligases in the PROTAC drug design.
Chen Y; Jin J
Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):776-790. PubMed ID: 32506133
[TBL] [Abstract][Full Text] [Related]
25. Proteolysis-targeting chimeras for targeting protein for degradation.
Qi J; Zhang G
Future Med Chem; 2019 Apr; 11(7):723-741. PubMed ID: 30706727
[TBL] [Abstract][Full Text] [Related]
26. PROTAC-DB: an online database of PROTACs.
Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
[TBL] [Abstract][Full Text] [Related]
27. Micellar Buchwald-Hartwig Coupling of Aryl and Heteroarylamines for the Synthesis of DNA-Encoded Libraries.
Graham JS; Hunter JH; Waring MJ
J Org Chem; 2021 Dec; 86(23):17257-17264. PubMed ID: 34788051
[TBL] [Abstract][Full Text] [Related]
28. Bulky alkylphosphines with neopentyl substituents as ligands in the amination of aryl bromides and chlorides.
Hill LL; Moore LR; Huang R; Craciun R; Vincent AJ; Dixon DA; Chou J; Woltermann CJ; Shaughnessy KH
J Org Chem; 2006 Jul; 71(14):5117-25. PubMed ID: 16808497
[TBL] [Abstract][Full Text] [Related]
29. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.
Xi M; Chen Y; Yang H; Xu H; Du K; Wu C; Xu Y; Deng L; Luo X; Yu L; Wu Y; Gao X; Cai T; Chen B; Shen R; Sun H
Eur J Med Chem; 2019 Jul; 174():159-180. PubMed ID: 31035238
[TBL] [Abstract][Full Text] [Related]
30. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
Gu S; Cui D; Chen X; Xiong X; Zhao Y
Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
[TBL] [Abstract][Full Text] [Related]
31. Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation.
Donoghue C; Cubillos-Rojas M; Gutierrez-Prat N; Sanchez-Zarzalejo C; Verdaguer X; Riera A; Nebreda AR
Eur J Med Chem; 2020 Sep; 201():112451. PubMed ID: 32634680
[TBL] [Abstract][Full Text] [Related]
32. Rapid room temperature Buchwald-Hartwig and Suzuki-Miyaura couplings of heteroaromatic compounds employing low catalyst loadings.
Navarro O; Marion N; Mei J; Nolan SP
Chemistry; 2006 Jun; 12(19):5142-8. PubMed ID: 16628762
[TBL] [Abstract][Full Text] [Related]
33. GPhos Ligand Enables Production of Chiral N-Arylamines in a Telescoped Transaminase-Buchwald-Hartwig Amination Cascade in the Presence of Excess Amine Donor.
Heckmann CM; Paradisi F
Chemistry; 2021 Dec; 27(67):16616-16620. PubMed ID: 34585789
[TBL] [Abstract][Full Text] [Related]
34. Applications and Limitations of Oxime-Linked "Split PROTACs".
Gui W; Kodadek T
Chembiochem; 2022 Sep; 23(18):e202200275. PubMed ID: 35802347
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of IAN-type N,N-Ligands via Dynamic Kinetic Asymmetric Buchwald-Hartwig Amination.
Ramírez-López P; Ros A; Romero-Arenas A; Iglesias-Sigüenza J; Fernández R; Lassaletta JM
J Am Chem Soc; 2016 Sep; 138(37):12053-6. PubMed ID: 27595166
[TBL] [Abstract][Full Text] [Related]
36. Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis.
Eleuteri M; Desantis J; Cruciani G; Germani R; Goracci L
Org Biomol Chem; 2024 May; 22(17):3477-3489. PubMed ID: 38602033
[TBL] [Abstract][Full Text] [Related]
37. Unparalleled rates for the activation of aryl chlorides and bromides: coupling with amines and boronic acids in minutes at room temperature.
Stambuli JP; Kuwano R; Hartwig JF
Angew Chem Int Ed Engl; 2002 Dec; 41(24):4746-8. PubMed ID: 12481346
[No Abstract] [Full Text] [Related]
38. Advancing targeted protein degrader discovery by measuring cereblon engagement in cells.
Zerfas BL; Huerta F; Liu H; Du G; Gray NS; Jones LH; Nowak RP
Methods Enzymol; 2023; 681():169-188. PubMed ID: 36764756
[TBL] [Abstract][Full Text] [Related]
39. Homo-PROTACs for the Chemical Knockdown of Cereblon.
Steinebach C; Lindner S; Udeshi ND; Mani DC; Kehm H; Köpff S; Carr SA; Gütschow M; Krönke J
ACS Chem Biol; 2018 Sep; 13(9):2771-2782. PubMed ID: 30118587
[TBL] [Abstract][Full Text] [Related]
40. General Method of Synthesis of 5-(Het)arylamino-1,2,3-triazoles via Buchwald-Hartwig Reaction of 5-Amino- or 5-Halo-1,2,3-triazoles.
Gribanov PS; Philippova AN; Topchiy MA; Minaeva LI; Asachenko AF; Osipov SN
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
